Evidence map›Paper›PMID 41039315›Full record

Trial reportBMC complementary medicine and therapies2025

Interest in complementary and alternative medicine among participants in a study on cancer prevention by green tea extract - results from an expert-based survey of MIRACLE trial participants.

Anna Melzer, Niklas Sturm, Friederike Rohlmann, Rainer Muche, Julia Stingl, Thomas J Ettrich, Thomas Seufferlein

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01360320 (Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01360320 phase2completednot on this map

Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-

TypeinterventionalSponsorMartin-Luther-Universität Halle-WittenbergRan2011 to 2019Enrolled1,001ConditionsColorectal Serrated Adenomas, Colorectal Tubular Adenomas, Colorectal Villous Adenomas, Colorectal Tubulovillous AdenomasArmsGreen tea extract of Camellia Sinensis, Green tea extract of Camellia Sinensis followed by placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna MelzerDepartment of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Niklas SturmDepartment of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Friederike RohlmannInstitute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
Rainer MucheInstitute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
Julia StinglDepartment of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Thomas J Ettrich *Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Thomas Seufferlein *Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany. Thomas.Seufferlein@Uniklinik-Ulm.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlthough chemopreventive strategies such as acetylsalicylic acid have shown potential in cancer prevention, they also entail adverse effects. This leads to growing interest in "natural" compounds, such as plant-based extracts, which may offer preventive benefits with fewer side effects. However, little is known aboutindividuals' personal attitudes towards conventional medications and complementary or alternative therapies when they are eligible for various cancer screening and prevention programmes. The present study aims to investigate the attitude toward medications and various therapies, as well as their prescription, among subjects participating in a clinical trial on the prevention of colorectal adenomas using green tea extract. A further goal was to assess whether the study predominantly attracted individuals with a strong preference for natural products or a more diverse set of opinions.

methods992 participants (age 50-80 years) of the MIRACLE study (a randomised study comparing green tea extract vs. placebo for secondary prevention of colorectal adenomas, NCT01360320) in 40 study centres across Germany received a 25-item, expert-based questionnaire regarding their attitude towards different medications and therapies including complementary and alternative medicine. Basic characteristics including age, gender, ECOG status, and lifestyle factors were also recorded. An exploratory factor analysis was used to group the items into eight thematic areas, which were then analysed for potential associations with the participants' baseline characteristics.

resultsResponse rate to the questionnaire was 94.3% (935/992). Survey participants mainly expressed positive attitudes towards both conventional and complementary medicine. Most were open to genetic testing for personalised treatment. Comparing the categories of the exploratory factor analysis revealed that female gender and regular exercise were associated with the regular use of alternative healing methods (i.e. acupuncture or homeopathic medicine). A more favourable view of alternative approaches was more common among younger and better-educated individuals, but the same groups also rated conventional medicine less negatively.

conclusionThe findings of this study reveal a relatively high level of openness towards both conventional and alternative medicine among participants of the MIRACLE trial, as well as certain features, such as age, gender, and education that impact on the attitude towards medications and therapies among participants in a study on secondary prevention of colorectal polyps by green tea extract.

trial registrationClinicalTrials.gov: NCT01360320.

Indexed as

Colorectal NeoplasmsComplementary TherapiesPlant ExtractsTeaAgedAged, 80 and overFemaleGermanyHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedSurveys and QuestionnairesPlant ExtractsTeaCancer preventionComplementary and alternative medicineConventional medicationFactor analysisGreen-tea extractSurvey

Identifiers

PMID41039315
PMCPMC12490030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.